AI Bias Analysis
4 models · Takes ~15 seconds
Quarterly RNA drug plozasiran turns off a liver gene, sharply lowering life‑threatening pancreatitis attacks in a rare genetic disorder.
Source
Forbes
Opens original article in a new tab
The index on Wednesday tallied its first intraday and closing record highs since the start of the Iran conflict.
Portal Innovations CEO John Flavin provides a look into the 2026 biotech M&A pipeline and breaks down Eli Lilly’s purported acquisition of CrossBridge Bio for up to $300 million, bolstering its oncology segment. He talks with Katie Greifeld and Romaine Bostick on “The Close.” (Source: Bloomberg)
The departure was announced alongside Ford detailing a new restructuring that includes the establishment of a "Product Creation and Industrialization" unit.
Goldman's identity as a trader's firm — one expected to perform in turbulent markets — makes any stumble in the division notable.
